Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to discover new ways to improve and extend people’s lives. We pioneer novel approaches to drive access to medicine. Our portfolio comprises over 1000 molecules and our products reach more than 500 million patients.
Sandoz is also on Twitter. Follow us on @Sandoz_global